Warning against use of injectable tanning products in Australia
- PDF / 151,424 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 41 Downloads / 167 Views
1
Warning against use of injectable tanning products in Australia The Australian Therapeutic Goods Administration (TGA) is warning against use of injectable tanning products such as afamelanotide (melanotan-I) and melanotan-II because of the risk of adverse events. They are not on the Australian Register of Therapeutic Goods, and the TGA has not assessed their efficacy, safety or quality. Reported adverse events associated with these drugs include darkened skin, increased moles and freckles, facial flushing, loss of appetite, nausea, vomiting, stretching and yawning, and spontaneous erections. Acne, and brain, heart and kidney disorders, have also been reported in the UK. Melanotan-I and -II are listed in Schedule 4 (prescription-only medicines) of the Poisons Standard in Australia, meaning they require close regulation and monitoring by the TGA and medical authorities, and have the potential to cause harm if not used under the supervision and instruction of a healthcare professional. They are not approved for marketing or sale in Australia and must not be advertised; it is illegal to import, export, manufacture or supply them. The TGA is currently investigating alleged illegal trade in performance and image-enhancing medicines, including melanotan products, in the Australian market. The TGA is advising Australian consumers that they should exercise extreme caution when purchasing any medicines online, especially unapproved products or those that require a prescription. Therapeutic Goods Administration. Beware the Barbie drug: the dangers of using melanotan. Internet Document : 13 Nov 2019. Available from: URL: https:// www.tga.gov.au/behind-news/beware-barbie-drug-dangers-using803435991 melanotan
0114-9954/19/1780-0001/$14.95 Adis © 2019 Springer Nature Switzerland AG. All rights reserved
Reactions 23 Nov 2019 No. 1780
Data Loading...
